MAM
Marquette Asset Management Portfolio holdings
AUM
$597M
This Quarter Return
+6.62%
1 Year Return
+14.22%
3 Year Return
+53.31%
5 Year Return
+85.41%
10 Year Return
+179.97%
AUM
$577M
AUM Growth
+$577M
(+6.3%)
Cap. Flow
-$1.57M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
77.36%
Holding
214
New
22
Increased
29
Reduced
39
Closed
17
Top Buys
Top Sells
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
$3.2M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
$792K |
| 3 |
LENZ
LENZ Therapeutics
LENZ
|
$786K |
| 4 |
Assembly Biosciences
ASMB
|
$604K |
| 5 |
USAP
Universal Stainless & Alloy
USAP
|
$329K |
Sector Composition
| 1 | Technology | 1.01% |
| 2 | Consumer Discretionary | 0.93% |
| 3 | Healthcare | 0.75% |
| 4 | Industrials | 0.57% |
| 5 | Communication Services | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.21B
| $189K | 0.03% | 4,066 | – | – |
|
77
Fonar
FONR
$101M
| $183K | 0.03% | 8,587 | – | – |
|
78
Vanguard Large-Cap ETF
VV
$44.5B
| $176K | 0.03% | 736 | – | – |
|
79
Fuel Tech
FTEK
$90.7M
| $171K | 0.03% | 141,189 +18,133 | +15% | +$21.9K |
|
80
3M
MMM
$82.8B
| $169K | 0.03% | 1,593 -92 | -5% | -$9.76K |
|
81
TAT Technologies
TATT
$470M
| $168K | 0.03% | 13,886 | – | – |
|
82
Miller Industries
MLR
$482M
| $165K | 0.03% | 3,300 -1,698 | -34% | -$85.1K |
|
83
Universal Electronics
UEIC
$64.8M
| $159K | 0.03% | +15,842 | New | +$159K |
|
|
ADAP
84
Adaptimmune Therapeutics
ADAP
$15.6M
| $156K | 0.03% | 98,589 | – | – |
|
85
AMREP Corp
AXR
$114M
| $151K | 0.03% | 6,484 | – | – |
|
86
Star Group
SGU
$392M
| $150K | 0.03% | 15,000 | – | – |
|
87
Caesarstone
CSTE
$49.1M
| $148K | 0.03% | 36,291 +6,006 | +20% | +$24.6K |
|
88
Wells Fargo
WFC
$263B
| $145K | 0.03% | 2,505 | – | – |
|
89
IBM
IBM
$227B
| $145K | 0.03% | 758 -200 | -21% | -$38.2K |
|
90
Intrepid Potash
IPI
$405M
| $144K | 0.02% | +6,893 | New | +$144K |
|
91
NETGEAR
NTGR
$788M
| $136K | 0.02% | 8,649 | – | – |
|
92
Bolt Biotherapeutics
BOLT
$9.85M
| $135K | 0.02% | 96,673 | – | – |
|
|
WHWK
93
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $135K | 0.02% | +57,807 | New | +$135K |
|
|
KLRS
94
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $135K | 0.02% | +178,883 | New | +$135K |
|
|
LENZ
95
LENZ Therapeutics
LENZ
$1.1B
| $131K | 0.02% | 5,865 -35,195 | -86% | -$786K |
|
96
NextCure
NXTC
$13.5M
| $130K | 0.02% | 58,259 | – | – |
|
97
Kodiak Sciences
KOD
$478M
| $126K | 0.02% | 23,930 -24,014 | -50% | -$126K |
|
|
IVAC
98
DELISTED
Intevac Inc
IVAC
| $126K | 0.02% | 32,777 | – | – |
|
99
Xcel Energy
XEL
$42.8B
| $124K | 0.02% | 2,300 +790 | +52% | +$42.5K |
|
|
CMRX
100
DELISTED
Chimerix, Inc.
CMRX
| $123K | 0.02% | 116,009 +22,709 | +24% | +$24.1K |
|